uk

Medscape

Medscape InDiscussion: Melanoma

Science EN ↓ Епізодів: 6

Join Dr Sapna Patel for Medscape InDiscussion: Melanoma, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/989030). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Обов'язково відвідайте сайт подкасту та підтримайте його автора: www.medscape.com

Автор

Medscape

Категорія

Science

Сайт подкасту

www.medscape.com

Останній епізод

18 жов 2023

Де слухати?

Подкасти в застосунку Replaio Radio Уже незабаром

Подкасти незабаром з'являться в застосунку. Встановіть уже зараз і першими побачте зовсім новий погляд на подкасти

Завантажити з Google Play Встановіть безкоштовно Android майже 10 млн завантажень · рейтинг 4,8 iOS незабаром

Епізоди

The Management of Melanoma in Community Oncology Practice 18.10.2023

Drs Patel, Wright, and Devoe revisit their involvement in the SWOG S1801 trial to highlight available resources that can expand the reach of cancer care in the community oncology setting. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/989040). The topics and discussions are planned, produced, and reviewed independently of advertisers...

Survivorship, Surveillance, and How Long to Follow a Melanoma Patient Population 19.09.2023

Five years, 7 years, or 10 years: How long should follow-up last in melanoma? Dr Sapna Patel and Professor James Larkin discuss the challenges and opportunities. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/989039). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended...

Liquid Biopsy in Melanoma 17.08.2023

Drs Sapna Patel and David Polsky explore biomarker development and the clinical utilization of liquid biopsy in melanoma. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/989037). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. R...

Emerging Data in Melanoma: What's New and What's Making a Splash 18.07.2023

Drs Sapna P. Patel and Kim A. Margolin sift through the data from studies presented at recent conferences, including the KEYNOTE-942 and RP1 IGNYTE studies. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/989036). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only...

How Do You Choose Treatment in the Frontline Setting for Metastatic Melanoma? 15.06.2023

Drs Sapna Patel and Yana Najjar analyze the data and share their approach to frontline therapy. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/989035). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Combination Dabra...

The Role of Adjuvant and Neoadjuvant Therapy in Melanoma: Why Use Adjuvant If There Are Neoadjuvant Data? 15.06.2023

Drs Sapna Patel and Matteo Carlino dive into the data and consider the current and future roles of adjuvant and neoadjuvant therapy. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/989030). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare profe...

Слухайте подкаст Medscape InDiscussion: Melanoma у Replaio

Радіо та подкасти в одному застосунку - безкоштовно й без реєстрації. Встановіть уже сьогодні та не пропустіть запуск

Завантажити з Google Play

Replaio не є видавцем подкастів; назви шоу, обкладинки та аудіо належать їхнім авторам і поширюються через публічні RSS-канали